Publication | Closed Access

Effects of short-term therapy with glibenclamide and repaglinide on incretin hormones and oxidative damage associated with postprandial hyperglycaemia in people with type 2 diabetes mellitus

ObesityMetabolic SyndromeDiabetes ManagementDiabetesPharmacologyType 2Diabetes MellitusIncretin HormonesShort-term TherapyEndocrinologyMedicine